Satoshi Ichikawa
8 Papers
3 Citations
Satoshi Ichikawa is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Solid-Phase Total Synthesis of Plusbacin A3.
Kazuki Takashina,Akira Katsuyama,Rintaro Kaguchi,Kazuki Yamamoto,Toyotaka Sato,Satoshi Takahashi,Motohiro Horiuchi,Shin-ichi Yokota,Satoshi Ichikawa +8 more
TL;DR: The total synthesis of the depsipeptide natural product plusbacin A3 utilizing solid-phase peptide synthesis (SPPS) was disclosed and a 3-hydroxy-proline derivative compatible with Fmoc SPPS was prepared.
5
Solid-Phase Total Synthesis of Sandramycin and Its Analogues.
Yuya Komatani,Kyoka Momosaki,Akira Katsuyama,Kazuki Yamamoto,Rintaro Kaguchi,Satoshi Ichikawa +5 more
TL;DR: In this article , a solid phase total synthesis of sandramycin (1), a C2-symmetric cyclic decadepsipeptide natural product, and its analogues is described.
4
Determining the structure of protein-bound ceramides, essential lipids for skin barrier function
Yusuke Ohno,Tetsuya Nakamura,Takafumi Iwasaki,Akira Katsuyama,Satoshi Ichikawa,Akio Kihara +5 more
TL;DR: The exact structure of protein-bound ceramide is determined as Cys-bound epoxy-enone ceramides where the β-carbon of the enone was attached by Cys residues of corneocyte surface proteins via a Michael addition reaction.
3
Solid-Phase Synthesis of Nannocystin Ax and Its Analogues.
TL;DR: In this article , a coupling reaction between a peptide and a polyketide moiety was conducted on a solid support, and macrocyclization was achieved by Mitsunobu cyclization.
1
Synthesis and biological evaluation of echinomycin analogues as potential colon cancer agent
Keita Kojima,Hiroaki Konishi,Kyoka Momosaki,Yuya Komatani,Akira Katsuyama,Koji Nakagawa,Kayoko Kanamitsu,Fumika Yakushiji,Mikihiro Fujiya,Satoshi Ichikawa +9 more
TL;DR: Data suggest that analogues of echinomycin, a cyclic peptide natural product with potent toxicity to several human cancer cell lines, are an attractive and potentially novel agent for the treatment of colon cancer.